For our clients, employees, and friends in the US, we hope you have a safe, healthy, and happy holiday weekend!
Despite the holiday, our call center is always open to support your business needs. Let us know how we can cover your call center, so you don’t have to work the holiday weekend next year: 877-477-0977 or https://medcommunications.com/contact-us/
#4thofJuly
At Med Communications, our services are flexible to meet your needs now and in the future. Our experienced and educated medical content development writers deliver high-quality scientific documents for our clients, and we pride ourselves on our on-time delivery. Whether you need help with one standard response letter or a whole database, we can scale up to help you get the job done.
If you need assistance with your manuscripts for scientific journals, formulary dossiers, slide decks, or promotional review, contact us: 877-477-0977 or https://medcommunications.com/contact-us/
#medicalwriting #therightpartner #therightresource
We have three new positions at our Memphis headquarters:
Medical Information Assistant https://recruiting.paylocity.com/Recruiting/Jobs/Details/293630
Medical Information Specialist https://recruiting.paylocity.com/Recruiting/Jobs/Details/296183
Pharmacovigilance Specialist https://recruiting.paylocity.com/Recruiting/Jobs/Details/301789
To apply: https://recruiting.paylocity.com/recruiting/jobs/List/3532/Med-Communications-Inc
#nowhiring
At Med Communications, our services are flexible to meet your needs now and in the future. Our highly qualified team of safety professionals adheres to good pharmacovigilance practices with timely regulatory screening and reporting of adverse events and product complaints. We can provide full-service pharmacovigilance services or specific services to add on to your company’s or other partner’s services, from medical reviews of cases to patient safety activities.
Not sure if your company or partner is covering all of the pharmacovigilance requirements in the US or around the world? Contact us to set up a call with our experienced pharmacovigilance professionals: 877-477-0977 or https://medcommunications.com/contact-us/
#pharmacovigilance #therightpartner #therightresource
At Med Communications, our services are flexible to meet your needs now and in the future. Our staff has the clinical expertise to address medical information questions quickly and accurately while possessing the sensitivity to help your customers and are available to take your calls 24 hours a day/ 7 days a week/ 365 days a year. Our multilingual staff is accessible via phone, email, webchat, video conferencing, and mobile devices. Language capabilities include English, French, German, Portuguese, and Spanish.
If you need any level of medical information call center, whether full-service or just services to add on to your normal call center offerings (such as after-hours or holidays), contact us: 877-477-0977 or https://medcommunications.com/contact-us/
#medicalinformation #therightpartner #therightresource
Med Communications is celebrating its 22nd year of business this month, and we want to let our clients, big and small, to know how much we appreciate their business!
We look forward to continuing to pursue our mission: Med Communications is passionate about delivering high-quality global medical affairs, pharmacovigilance, and commercial solutions to pharmaceutical, biotech, and device companies. We do this by building lasting partnerships with our clients while providing employees with a meaningful professional experience.
If you need full-service medical information call center, pharmacovigilance, or medical writing, contact us: 877-477-0977 or https://medcommunications.com/contact-us/
#medicalinformation #medicalwriting # pharmacovigilance
The contents of the Approved Product Dossier do not change in the new AMCP Format for Formulary Dossiers, but there is so much to talk about with this type of dossier, so we have been covering it section by section in the past weeks.
The contents of Section 6 are pretty self-explanatory. It contains all of the references for the dossier, any economic models discussed in Section 5, a copy of the approved Prescribing Information, any patient information, and a Material Safety Data Sheet (MSDS).
AMCP Format v4.1 Posts_AMCP_Approved_Section 6
If you need any assistance with creating or updating your dossier, let us know: 877-477-0977 or https://medcommunications.com/contact-us/
#AMCP #dossierwriting #managedcare
The contents of the Approved Product Dossier do not change in the new AMCP Format for Formulary Dossiers, but there is so much to talk about with this type of dossier, so we will be covering it section by section in the coming weeks.
Section 5 can provide additional types of evidence and studies that did not fit into Section 3.0B, such as clinical practice guidelines, HTAs and systematic review, compendia, modeling, and pharmacoeconomic studies. Many dossiers only have information in a section or two of Section 5, but it’s available if there are other types of evidence to provide to health care decision makers.
AMCP Format v4.1 Posts_AMCP_Approved_Section 5
Follow our page to keep up with all of the sections of the new AMCP Format for Formulary Submissions. If you need any assistance with creating or updating your dossier, let us know: 877-477-0977 or https://medcommunications.com/contact-us/
#AMCP #dossierwriting #managedcare
The contents of the Approved Product Dossier do not change in the new AMCP Format for Formulary Dossiers, but there is so much to talk about with this type of dossier, so we will be covering it section by section in the coming weeks.
Section 4 provides guidance for different types of models used to show the economic value of a product. Depending on the models available, this section could be really short or longer given the level of detail required to evaluate the models.
AMCP Format v4.1 Posts_AMCP_Approved_Section Four
Follow our page to keep up with all of the sections of the new AMCP Format for Formulary Submissions. If you need any assistance with creating or updating your dossier, let us know: 877-477-0977 or https://medcommunications.com/contact-us/
#AMCP #dossierwriting #managedcare
The contents of the Approved Product Dossier do not change in the new AMCP Format for Formulary Dossiers, but there is so much to talk about with this type of dossier, so we will be covering it section by section in the coming weeks.
Section 3 may be the second-longest section in any dossier, as it is based on the level of evidence available for a product at the time the dossier is created or updated. Section 3 contains the clinical evidence, which is displayed through study summaries and evidence tables.
AMCP Format v4.1 Posts_AMCP_Approved_Section 3
Follow our page to keep up with all of the sections of the new AMCP Format for Formulary Submissions. If you need any assistance with creating or updating your dossier, let us know: 877-477-0977 or https://medcommunications.com/contact-us/
#AMCP #dossierwriting #managedcare
